McKesson Corporation Stock News

McKesson has offered investors safety and growth.

The heavy selling pressure might have exhausted for McKesson (MCK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Warren Buffett is known for picking great businesses.

This Buffett-backed business leads the medical distribution industry.

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for MCL.

Buffett's company Berkshire Hathaway spent more time selling stocks than buying in the fourth quarter of 2022.

Digging into three highly-ranked stocks that outperformed the market in 2022 amid the turmoil and are primed to keep running higher in 2023 even if Wall Street is forced to take its foot off the growt

The heavy selling pressure might have exhausted for McKesson (MCK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in

McKesson (MCK) could produce exceptional returns because of its solid growth attributes.

Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.

McKesson's (MCK) third-quarter fiscal 2023 results benefit from segmental growth.

McKesson Corporation (NYSE:MCK ) Q3 2023 Results Conference Call February 1, 2023 4:30 PM ET Company Participants Rachel Rodriguez - VP, IR Brian Tyler - CEO Britt Vitalone - CFO Conference Call Parti

McKesson (MCK) delivered earnings and revenue surprises of 8.83% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Here is how McKesson (MCK) and Annovis Bio, Inc. (ANVS) have performed compared to their sector so far this year.